Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Medical research involves research in a wide range of fields, such as biology, chemistry, pharmacology and toxicology with the goal of developing new medicines or medical procedures or improving ...

VeChain embraces EVM compatibility and JSON RPC integration to strengthen interoperability and enterprise adoption. The new upgrades position VeChain for long-term growth, developer accessibility, and ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

VeChain (VET) price analysis for February 13 shows a significant price drop of 30% over the last seven days, trading at $0.04706 as of the latest update. The day’s low was recorded at $0.04298, while ...

The current price of VeChain (VET) is $0.031729, as of February 18, 2025. Over the last 24 hours, the price has moved by -4.22%, with a change of -0.55% in the past hour. For longer-term performance, ...

Even everyday stress, the kind that many people experience, impairs the cancer-fighting immune system.

French shipping giant CMA CGM is joining forces with Energy Observer within a project focusing on testing the potential of hydrogen as a marine fuel.Energy Observer, formerly a racing catamaran, is ...

J.P. Morgan analysts said the findings of J&J’s investigation “could significantly hinder the product’s rollout in the U.S. and globally” and lead doctors to “de-prioritize Varipulse.” Lynlee Brown, a ...